|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320 AUD | -0.90% |
|
+0.55% | +7.14% |
| Apr. 22 | Cochlear Limited Announces Company Secretary Changes | CI |
| Apr. 19 | Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old | CI |
(Reuters) - UK's competition regulator will refer Australian hearing device maker Cochlear's acquisition of Copenhagen-based Demant's hearing implants business Oticon Medical for an in-depth investigation.
UK's Competition and Markets Authority (CMA) said on Tuesday it will refer the 850 million Danish crowns ($121.14 million) deal to a phase 2 investigation as it could threaten competition.
($1 = 7.0167 Danish crowns)
(Reporting by Sinchita Mitra in Bengaluru; Editing by Rashmi Aich)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 320 AUD | -0.90% | +0.55% | 13.6B | ||
| 319.7 DKK | -0.34% | +2.89% | 10.01B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +7.14% | 13.6B | |
| +2.47% | 23.92B | |
| -7.91% | 16.65B | |
| +8.11% | 10.01B | |
| -19.75% | 2.01B | |
| +12.20% | 1.88B | |
| +34.39% | 1.67B | |
| 0.00% | 492M | |
| +31.01% | 139M | |
| +30.56% | 104M |
COCHLEAR LIMITED 
